logo

For the Inventor, By the Inventor

Kamataka, India

Shilpa Medicare Limited


USPTO Granted Patents = 32

% Expired Patents = 59.4


Trademarks = 1

Forward Citations = 24

Loading Chart...
Loading Chart...

53 inventors (with patents filed for the assignee):

goldMedal Shivakumar Pradeep (9 out of 9 patents)

silverMedal Sreenivasa Reddy (8 out of 11 patents)

bronzeMedal Prashant Purohit (7 out of 7 patents)

4.  Vimal Kumar Shrawat (7 out of 7 patents)

5.  Akshay Kant Chaturvedi (6 out of 7 patents)

6.  Vinod Kumar Singh (5 out of 5 patents)

7.  Vara Prasad Rangabhatla Gunneswara Subramanya (4 out of 4 patents)

8.  Ratna Phani Ayalasomayajula (4 out of 4 patents)

9.  Akshaykant Chaturvedi (4 out of 4 patents)

10.  Rafiuddin Dr (4 out of 5 patents)

11.  Sriram Rampalli (3 out of 4 patents)

12.  Nagnnath Kokare (3 out of 3 patents)

13.  Rafiuddin (3 out of 3 patents)

14.  Pradeep Shivakumar (3 out of 4 patents)

15.  Lav Kumar Upalla (2 out of 3 patents)


Core Competencies:
Ondansetron
Abiraterone Acetate
Dutasteride
Docetaxel
Brinzolamide
Paracetamol
Tranexamic Acid
Lenvatinib
Vemurafenib
Fingolimod
Bortezomib
Cabazitaxel

32 patents:

1. 12508247 - Controlled release injectable ondansetron formulations (2025-12-30),
2. 12403149 - Dispersible tablets of abiraterone acetate (2025-09-02),
3. 11857680 - Composition of docetaxel liposomal injection with high drug loading (2024-01-02),
4. 11857556 - Topical compositions of dutasteride (2024-01-02),
5. 11533929 - Green tea film composition (2022-12-27),
6. 11298360 - Ophthalmic compositions of brinzolamide (2022-04-12),
7. 11202756 - Oral disintegrating film compositions of paracetamol (2021-12-21),
8. 10993934 - Topical compositions of dutasteride (2021-05-04),
9. 10980740 - Tranexamic acid spray for knee arthroplasty (2021-04-20),
10. 10842771 - Composition of docetaxel liposomal injection with high drug loading (2020-11-24),
11. 10722498 - Acetazolamide ophthalmic solution (2020-07-28),
12. 10702578 - Ophthalmic compositions of cyclosporine (2020-07-07),
13. 10682326 - Stable melphalan liquid injectable formulations (2020-06-16),
14. 10583216 - Scaffold compositions for tissue repair (2020-03-10),
15. 10583133 - Pharmaceutical compositions of lenvatinib (2020-03-10),
Company Overview
Shilpa Medicare Limited is a prominent pharmaceutical company based in Karnataka, India, specializing in the development and manufacturing of a diverse range of generic and specialty medications. The company focuses on complex generics, biosimilars, and active pharmaceutical ingredients (APIs), catering to both domestic and international markets. With a commitment to innovation, Shilpa Medicare invests in advanced research and technology to enhance drug delivery systems and improve patient outcomes, positioning itself as a key player in the global healthcare landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

32 Patents

#1 in

#63 in

#20,671 in the World

Kamataka, IN
Kamataka, India

Shilpa Medicare Limited

Forward Citations = 24

53 inventors:

goldMedal Shivakumar Pradeep (9 out of 9 patents)

silverMedal Sreenivasa Reddy (8 out of 11 patents)

bronzeMedal Prashant Purohit (7 out of 7 patents)

4.  Vimal Kumar Shrawat (7 out of 7 patents)

5.  Akshay Kant Chaturvedi (6 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Shilpa Medicare Limited. Retrieved from https://idiyas.com/company/shilpa-medicare

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…